As the first to trial the CRISPR-Cas9 technology on patients, the West China Hospital in Chengdu signalled its innovative spirit and capacity to break new ground. The gene editing tool has been ...

A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...

The advent of CRISPR/Cas9 technology has provided a new approach for genome visualization. Originally discovered as a bacterial adaptive immune system, the CRISPR/Cas9 system has been repurposed ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

CRISPR-Cas9 is not the first method available to scientists for modifying DNA; it is by far, however, the easiest to use. With CRISPR-Cas9, the crRNA/tracrRNA sequence or an artificial guide RNA ...

A new type of therapy that ‘edits’ a gene in patients with a rare heart condition has been shown to be safe and effective, ...

Genome Editing Market Size Was Valued at USD 7.39 Billion in 2023, and is Projected to Reach USD 30.78 Billion by 2032, ...

CRISPR/Cas9 is a form of gene editing that allows a person’s DNA to be modified as a therapy to potentially cure diseases. One of the two scientists credited with inventing this technology ...

A single treatment with, a CRISPR-Cas9-based gene editing therapy, is enough to replace the daily medication ... internist at Amsterdam UMC and first author of the study. Subscribe to Technology ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...